Anti-Histone H3 (citrulline R26) antibody [EPR20606]
- RabMAb
- Recombinant
- What is this?
5
(2 Reviews)
|
(5 Publications)
Rabbit Recombinant Monoclonal H3 citrulline R26 antibody. Suitable for ELISA, Dot, WB and reacts with Synthetic peptide, Mouse, Human samples. Cited in 5 publications.
View Alternative Names
H3FA, HIST1H3A, H3C2, H3FL, HIST1H3B, H3C3, H3FC HIST1H3C, H3C4, H3FB, HIST1H3D, H3C6, H3FD, HIST1H3E, H3C7, H3FI, HIST1H3F, H3C8, H3FH, HIST1H3G, H3C10, H3FK, HIST1H3H, H3C11, H3FF, HIST1H3I, H3C12, H3FJ, HIST1H3J, H3FC, HIST1H3C, H3C1, Histone H3.1, Histone H3/a, Histone H3/b, Histone H3/c, Histone H3/d, Histone H3/f, Histone H3/h, Histone H3/i, Histone H3/j, Histone H3/k, Histone H3/l, H3R26cit
- ELISA
Unknown
ELISA - Anti-Histone H3 (citrulline R26) antibody [EPR20606] (AB212082)
ELISA using ab212082 labeling Histone H3 (Citrulline R26) Histone H3R26 unmodified Histone H3 (Citrulline R17) Histone H3 (Citrulline R8) Histone H3 (Citrulline R2) and Histone H3R2/8/17 unmodified at 1 μg/ml. ab212082 was used at a range between 0 -1 μg/ml.
Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) was used as secondary antibody at 1/2500 dilution.
ab212082 cross binds H3R8Cit at 14%.
- WB
Supplier Data
Western blot - Anti-Histone H3 (citrulline R26) antibody [EPR20606] (AB212082)
Histone H3R26 is citrullinated by PADI4, CaCl2 is used as a co-factor according to the literature (PMID : 16567635). Ionomycin is used to improve the modification by PADI4 according to the literature (PMID : 26360112).
Blocking/Dilution buffer : 5% BSA/TBST.
All lanes:
Western blot - Anti-Histone H3 (citrulline R26) antibody [EPR20606] (ab212082) at 1/1000 dilution
Lane 1:
HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) transfected with an empty vector (control) then treated with 10 mM CaCl2 and 10 μM Ionomycin for 2 hours, whole cell lysate at 10 µg
Lane 2:
HEK-293T transfected with a GFP-tagged PADI4 expression vector then treated with 10 mM CaCl2 and 10 μM Ionomycin for 2 hours, whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 15 kDa
Observed band size: 15 kDa
true
Exposure time: 5s
- WB
Supplier Data
Western blot - Anti-Histone H3 (citrulline R26) antibody [EPR20606] (AB212082)
Histone H3R26 is citrullinated by PADI4, CaCl2 is used as a co-factor according to the literature (PMID : 16567635). Ionomycin is used to improve the modification by PADI4 according to the literature (PMID : 26360112).
Blocking/Dilution buffer : 5% BSA/TBST.
All lanes:
Western blot - Anti-Histone H3 (citrulline R26) antibody [EPR20606] (ab212082) at 1/1000 dilution
Lane 1:
NIH/3T3 (mouse embryonic fibroblast cell line) transfected with a GFP-tagged empty vector (control) then treated with 10 mM CaCl2 for 2 hours, whole cell lysate at 10 µg
Lane 2:
NIH/3T3 transfected with a GFP-tagged PADI4 expression vector treated with 10 mM CaCl2 for 2 hours, whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 15 kDa
Observed band size: 15 kDa
false
Exposure time: 3min
- Dot
Supplier Data
Dot Blot - Anti-Histone H3 (citrulline R26) antibody [EPR20606] (AB212082)
Dot blot analysis of Histone H3 (citrulline R26) labeled with ab212082 at 1/1000 dilution.
Lane 1 : Histone H3 (citrulline R26) peptide (aa25-36)
Lane 2 : Histone H3 (Citrulline R17) peptide (aa1-21)
Lane 3 : Histone H3 (Citrulline R8) peptide (aa1-21)
Lane 4 : Histone H3 (Citrulline R2) peptide (aa1-21)
Lane 5 : Histone H3 peptide (aa1-21)
Lane 6 : Histone H3 peptide (aa19-36)
Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution was used as secondary antibody.
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 30 seconds.
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
iScience 28:113485 PubMed41019372
2025
Applications
Unspecified application
Species
Unspecified reactive species
European journal of immunology 55:e202451298 PubMed39508544
2024
Applications
Unspecified application
Species
Unspecified reactive species
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 378:20220248 PubMed37778388
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cells 11: PubMed36010543
2022
Applications
Unspecified application
Species
Unspecified reactive species
Immunity 53:805-823.e15 PubMed33053330
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com